VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,187,070 | +35.8% | 145,529 | +17.8% | 0.19% | +23.5% |
| Q2 2023 | $874,052 | +30752.5% | 123,520 | -48.9% | 0.15% | -65.5% |
| Q1 2023 | $2,833 | +84.4% | 241,952 | -81.0% | 0.44% | +184.0% |
| Q4 2022 | $1,536 | -99.6% | 1,270,281 | +12.8% | 0.16% | +437.9% |
| Q3 2022 | $432,000 | -76.0% | 1,125,800 | -0.8% | 0.03% | -67.8% |
| Q2 2022 | $1,802,000 | -73.9% | 1,135,133 | -5.5% | 0.09% | -68.9% |
| Q1 2022 | $6,901,000 | +17.6% | 1,200,700 | -44.2% | 0.29% | +80.6% |
| Q4 2021 | $5,866,000 | -65.4% | 2,151,995 | +47.6% | 0.16% | -71.0% |
| Q3 2021 | $16,931,000 | +157.7% | 1,457,752 | +30.9% | 0.55% | +168.8% |
| Q2 2021 | $6,570,000 | +8.4% | 1,113,484 | +25.7% | 0.20% | -36.7% |
| Q1 2021 | $6,059,000 | +1.2% | 885,853 | -23.1% | 0.32% | +88.4% |
| Q4 2020 | $5,989,000 | -52.6% | 1,151,257 | +3.2% | 0.17% | -72.4% |
| Q3 2020 | $12,630,000 | -6.1% | 1,115,832 | -21.5% | 0.62% | -15.7% |
| Q2 2020 | $13,456,000 | +301.7% | 1,420,780 | +231.5% | 0.74% | +229.9% |
| Q1 2020 | $3,350,000 | +245.0% | 428,540 | -67.4% | 0.22% | +322.6% |
| Q4 2019 | $971,000 | -95.9% | 1,313,800 | -65.5% | 0.05% | -97.3% |
| Q3 2019 | $23,744,000 | +1240.7% | 3,805,554 | +228.5% | 1.94% | +1334.8% |
| Q2 2019 | $1,771,000 | -50.8% | 1,158,416 | +15.0% | 0.14% | -57.8% |
| Q1 2019 | $3,596,000 | -81.4% | 1,007,367 | -63.4% | 0.32% | -73.7% |
| Q4 2018 | $19,357,000 | -22.8% | 2,749,918 | -9.8% | 1.22% | -22.9% |
| Q3 2018 | $25,069,000 | +133.6% | 3,049,132 | +60.3% | 1.58% | +195.7% |
| Q2 2018 | $10,731,000 | +18.4% | 1,901,948 | +28.4% | 0.54% | +17.8% |
| Q1 2018 | $9,067,000 | +49.7% | 1,480,952 | -21.7% | 0.45% | +79.4% |
| Q4 2017 | $6,057,000 | +70.2% | 1,891,228 | +49.0% | 0.25% | +49.7% |
| Q3 2017 | $3,558,000 | -57.8% | 1,269,265 | -21.6% | 0.17% | -62.5% |
| Q2 2017 | $8,431,000 | +128.4% | 1,618,694 | +44.1% | 0.45% | +96.9% |
| Q1 2017 | $3,692,000 | -66.4% | 1,123,502 | -72.4% | 0.23% | -58.5% |
| Q4 2016 | $10,989,000 | +156.1% | 4,070,999 | +21.3% | 0.55% | +265.6% |
| Q3 2016 | $4,291,000 | -36.3% | 3,356,500 | -1.1% | 0.15% | -61.7% |
| Q2 2016 | $6,733,000 | – | 3,393,800 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |